Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Caliper Life Sciences, AntiCancer to Cross License

Mar 2008
Caliper Life Sciences Inc. of Hopkinton, Mass., and AntiCancer Inc. of San Diego, have agreed to establish a cross-licensing relationship and to terminate all outstanding patent litigation between themselves. As part of the agreement, Caliper will acquire the right to sublicense AntiCancer’s fluorescent protein optical imaging patents to third parties. In turn, AntiCancer will acquire the right to sublicense Caliper’s optical imaging patents, in the field of fluorescent protein images, to a specified number of third parties on an annual basis throughout the life of the agreement. Each company will receive a royalty-free license from the other for internal and contract research operations.

BiophotonicsCaliper Life Sciences Inc.fluorescent proteinNews & Featuresoptical imaging

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.